Recent study conducted by Caushi et al. aimed to evaluate the role of Elisa IgG serum antibody titres in diagnosing pulmonary ...
The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.
Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback